Session 4C: From innovation to first-in-human trials: Practical guidance for using New Approach Methodologies (NAMs) in Australia
Tracks
Track 3
| Wednesday, October 21, 2026 |
| 4:30 PM - 5:15 PM |
| Discovery & Advanced Therapeutics Breakout Room |
Details
New Approach Methodologies (NAMs) are increasingly being used to strengthen translational confidence, reduce reliance on animal models and support safer progression into first-in-human trials.
The next challenge is practical: how should NAM evidence be generated, presented, assessed and used by sponsors, Phase 1 sites, HRECs and regulators?
Building on Bellberry and ASCEPT’s 2025 NAM Workshop 2 and double panel session at AusBiotech, this session will explore the practical application of Bellberry and ASCEPT guidance for the use of NAMs in first-in-human and early phase trials.
The panel will bring together perspectives from a Phase 1 site, sponsor, technologist and the TGA to discuss what credible, consistent and useful NAM evidence looks like in practice.
Speaker
Dr. Michael Phelan
Principal Consultant
InnovApproach Consulting
Panellist